Literature DB >> 27543985

Differential Regulatory Role of Soluble Klothos on Cardiac Fibrogenesis in Hypertension.

Xue Liu1, Yuanjian Chen2, Cody W McCoy2, Tieqiang Zhao2, Darryl L Quarles3, Min Pi3, Syamal K Bhattacharya2, Gwendalyn King4, Yao Sun5.   

Abstract

BACKGROUND: Soluble Klotho functions as an endocrine factor that plays important roles in a variety of pathophysiological processes. Soluble Klotho contains 130 KDa and 65 KDa isoforms. However, their distinct individual functional heterogeneity remains uncertain. Herein, we investigated the regulatory role of two soluble Klothos on cardiac fibrogenic responses. METHODS AND
RESULTS: The effect of soluble Klothos on myofibroblast differentiation, proliferation, and collagen synthesis/degradation were examined in cultured mouse cardiac myofibroblasts. The role of 130 KDa Klotho on fibrosis in hypertensive heart disease were examined in wild type (WT) and Klotho transgenic (Tg/+) mice receiving chronic angiotensin (Ang)II infusion. Our in vitro studies revealed that addition of 130 KDa soluble Klotho isoform increased collagen synthesis in a dose dependent manner. Furthermore, 130 KDa Klotho significantly stimulated myofibroblast differentiation, proliferation, and ERK phosphorylation, which were abolished by fibroblast growth factor (FGF) receptor antagonist (SU5402). In contrast, 65 KDa soluble Klotho treatment significantly suppressed myofibroblast proliferation and collagen synthesis. In vivo study further demonstrated that chronic AngII infusion lead to cardiac fibrosis in both WT and Tg/+ mice. However, cardiac collagen, TGF-β1, TIMP-2, and α-smooth muscle actin (SMA) levels were markedly upregulated in Tg/+ mice compared to WT cohort.
CONCLUSION: Taken together, these findings implicate that 130 KDa soluble Klotho plays a stimulatory role in cardiac myofibroblast growth and activity through FGF pathway, whereas 65 KDa soluble Klotho exerts an anti-fibrotic effect in cardiac myofibroblasts. Thus, two distinct isoforms of soluble Klotho appear to play the counter-regulatory roles in cardiac fibrogenic responses. © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cardiac fibrosis; hypertension; hypertensive heart disease; myofibroblasts; soluble klotho.

Mesh:

Substances:

Year:  2016        PMID: 27543985      PMCID: PMC5018999          DOI: 10.1093/ajh/hpw062

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  39 in total

Review 1.  Klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Contrib Nephrol       Date:  2013-05-03       Impact factor: 1.580

2.  Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart.

Authors:  Y Sun; K T Weber
Journal:  J Mol Cell Cardiol       Date:  1996-05       Impact factor: 5.000

3.  Ascending Aortic Aneurysm in Angiotensin II-Infused Mice: Formation, Progression, and the Role of Focal Dissections.

Authors:  Bram Trachet; Alessandra Piersigilli; Rodrigo A Fraga-Silva; Lydia Aslanidou; Jessica Sordet-Dessimoz; Alberto Astolfo; Marco F M Stampanoni; Patrick Segers; Nikolaos Stergiopulos
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-18       Impact factor: 8.311

4.  Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.

Authors:  Enrico Patrucco; Katrin Domes; Mauro Sbroggió; Anne Blaich; Jens Schlossmann; Matthias Desch; Sergei D Rybalkin; Joseph A Beavo; Robert Lukowski; Franz Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-19       Impact factor: 11.205

5.  Protective role of Klotho on cardiomyocytes upon hypoxia/reoxygenation via downregulation of Akt and FOXO1 phosphorylation.

Authors:  Fen Ai; Manhua Chen; Wei Li; Yang Yang; Guizhong Xu; Feng Gui; Zhenxing Liu; Xiangyan Bai; Zhen Chen
Journal:  Mol Med Rep       Date:  2014-11-07       Impact factor: 2.952

6.  Klotho protects against mouse renal fibrosis by inhibiting Wnt signaling.

Authors:  Minoru Satoh; Hajime Nagasu; Yoshitaka Morita; Terry P Yamaguchi; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-03

7.  Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

8.  TGF-β-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms.

Authors:  Matthias A Scharenberg; Benjamin E Pippenger; Ragna Sack; Dominik Zingg; Jacqueline Ferralli; Susanne Schenk; Ivan Martin; Ruth Chiquet-Ehrismann
Journal:  J Cell Sci       Date:  2014-01-14       Impact factor: 5.285

Review 9.  Klotho: a tumor suppressor and modulator of the Wnt/β-catenin pathway in human hepatocellular carcinoma.

Authors:  Xiaowei Tang; Yun Wang; Zhining Fan; Guozhong Ji; Min Wang; Jie Lin; Shu Huang; Stephen J Meltzer
Journal:  Lab Invest       Date:  2015-08-03       Impact factor: 5.662

10.  Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II.

Authors:  Y Sun; A Ratajska; K T Weber
Journal:  J Lab Clin Med       Date:  1995-07
View more
  14 in total

1.  Human alternative Klotho mRNA is a nonsense-mediated mRNA decay target inefficiently spliced in renal disease.

Authors:  Rik Mencke; Geert Harms; Jill Moser; Matijs van Meurs; Arjan Diepstra; Henri G Leuvenink; Jan-Luuk Hillebrands
Journal:  JCI Insight       Date:  2017-10-19

Review 2.  αKlotho-FGF23 interactions and their role in kidney disease: a molecular insight.

Authors:  Edward R Smith; Stephen G Holt; Tim D Hewitson
Journal:  Cell Mol Life Sci       Date:  2019-07-26       Impact factor: 9.261

3.  Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Yuanjian Chen; Syamal K Bhattacharya; Lu Lu; Yao Sun
Journal:  Am J Hypertens       Date:  2017-12-08       Impact factor: 2.689

4.  FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.

Authors:  Zhousheng Xiao; Gwendalyn King; Salvatore Mancarella; Undral Munkhsaikhan; Li Cao; Chun Cai; Leigh Darryl Quarles
Journal:  JCI Insight       Date:  2019-12-05

5.  Associations Between Serum Soluble α-Klotho and the Prevalence of Specific Cardiovascular Disease.

Authors:  Jun-Peng Xu; Rui-Xiang Zeng; Mu-Hua He; Shan-Shan Lin; Li-Heng Guo; Min-Zhou Zhang
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 6.  Fibroblast growth factor 23 and α-Klotho co-dependent and independent functions.

Authors:  L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

7.  Cardiovascular Effects of Renal Distal Tubule Deletion of the FGF Receptor 1 Gene.

Authors:  Xiaobin Han; Jed Ross; Ganesh Kolumam; Min Pi; Junichiro Sonoda; Gwendalyn King; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

8.  Lower urinary α-Klotho is associated with lower angiotensin-(1-7) and higher blood pressure in young adults born preterm with very low birthweight.

Authors:  Andrew M South; Hossam A Shaltout; TanYa M Gwathmey; Elizabeth T Jensen; Patricia A Nixon; Debra I Diz; Mark C Chappell; Lisa K Washburn
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-05-31       Impact factor: 3.738

9.  Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.

Authors:  Maren Leifheit-Nestler; Beatrice Richter; Melis Basaran; Julia Nespor; Isabel Vogt; Ioana Alesutan; Jakob Voelkl; Florian Lang; Joerg Heineke; Stefanie Krick; Dieter Haffner
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-21       Impact factor: 5.555

10.  Cardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II.

Authors:  Min Pi; Ruisong Ye; Xiaobin Han; Benjamin Armstrong; Xue Liu; Yuanjian Chen; Yao Sun; L Darryl Quarles
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.